An innovative synthetic biology approach may have the potential to enhance phage therapeutics and the role a biofoundry can play in bringing phage therapy to fruition.
Directed Evolution (DE) is a method developed by Nobel laureate Frances Arnold to improve protein fitness for specific applications. However, DE can be less efficient…
Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, judging by how flat the company’s shares fared this…
Researchers used gene therapy to convert harmful fatty acids into beneficial ones to help combat childhood obesity.
Researchers suggest findings could help to pinpoint cell types most vulnerable to conditions such as schizophrenia, and autism spectrum disorder.
Even as the world continues to recover from the COVID pandemic, the threat of another global health crisis seems assured. Before that happens, it will…
Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing bystander immunity.
Rather than decry billionaires in space, consider the billions of people with a stake in space exploration.
Whereas Biopharma 4.0 prioritizes productivity, Biopharma 5.0 emphasizes environmental and social sustainability.
The organoid field is advancing rapidly and, in turn, speeding up the pace of research and discovery. From neurons to cancer, organoid models are uncovering…
By leveraging AI, drug developers are moving beyond incremental gains in efficiency and engaging previously undruggable targets.
